QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

https://www.wsj.com/health/pharma/pfizer-covid-vaccine-2020-election-probe-2f3ec247

 fda-approves-exelixis-lead-cancer-drug-cabometyx-for-expanded-use-in-neuroendocrine-tumors

Exelixis' Cabometyx gains FDA approval for advanced neuroendocrine tumors, while phase 3 data confirms sustained survival b...

Core News & Articles

https://www.nytimes.com/2025/03/26/health/usaid-c

Core News & Articles

ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. and Shionogi a...

 china-courts-apple-pfizer-eli-lilly-amid-us-pressure-vice-premier-says-beijing-will-continue-to-improve-the-business-environment

China is stepping up efforts to reassure U.S. corporate giants like Apple, Pfizer, and Mastercard of its economic potential, wi...

 pharmaceutical-firms-say-uk-investment-is-unlikely-unless-payment-levy-is-adressed

UK pharma leaders warn excessive NHS levies threaten industry growth, urging the government to reform payments. The ABPI highli...

 pfizer-offloads-its-last-7-stake-in-consumer-health-haleon-for-over-3-billion

Pfizer has completed its exit from Haleon, selling its entire stake for $3.1 billion. BlackRock's unit is now Haleon's ...

 trump-administration-weighs-deep-cuts-to-domestic-hiv-prevention-programs-gilead-stock-slides

HHS is considering major cuts to federal HIV prevention funding as part of a CDC reorganization, potentially affecting programs...

Core News & Articles

- Reuters Citing Citigroup Global Market

 guggenheim-reiterates-buy-on-pfizerto-buy

Guggenheim analyst Vamil Divan reiterates Pfizer (NYSE:PFE) from Buy to Buy.

 protalix-biotherapeutics-says-with-debt-fully-repaid-its-well-positioned-to-execute-strategy-through-2025-and-beyond

Protalix saw record revenue growth in 2024, driven by increased sales to Chiesi, Pfizer, and Brazil. The company aims to start ...

 pfizers-direct-to-consumer-model-faces-scrutiny-from-us-senators-corrected

Senators question Pfizer's partnership with UpScriptHealth, citing potential anti-kickback concerns and risks of increased ...

 gsk-pfizers-viiv-healthcare-shows-strong-hiv-viral-suppression-in-latest-study

ViiV Healthcare's EMBRACE study shows VH109 with CAB LA effectively suppresses HIV. The company also reports promising earl...

Core News & Articles

https://www.statnews.com/2025/03/12/telehealth-platforms-senators-crosshairs-over-relationship-with-eli-lilly-pfizer/#:~:text=T...

Core News & Articles

Results from the phase IIb study, EMBRACE, demonstrate that N6LS, a bNAb administered every four months, effectively maintained...

 guggenheim-reiterates-buy-on-pfizerto-buy

Guggenheim analyst Vamil Divan reiterates Pfizer (NYSE:PFE) from Buy to Buy.

 arvinas-pfizer-breast-cancer-drug-fails-to-show-progression-free-survival-benefit-in-trial

Arvinas and Pfizer's Phase 3 trial shows vepdegestrant significantly improves progression-free survival in breast cancer pa...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION